Epidemiological considerations in planning HIV preventive vaccine trials

This publication has 77 references indexed in Scilit:

• Current Issues in HIV Vaccine Development
  Journal of Health Management, 2000
• A Comparison of Full-Length Glycoprotein 120 from Incident HIV Type 1 Subtype E and B Infections in Bangkok Injecting Drug Users with Prototype E and B Strains That Are Components of a Candidate Vaccine
  AIDS Research and Human Retroviruses, 2000
• Biological Considerations in the Development of a Human Immunodeficiency Virus Vaccine
  The Journal of Infectious Diseases, 2000
• A Phase II Study of Two HIV Type 1 Envelope Vaccines, Comparing Their Immunogenicity in Populations at Risk for Acquiring HIV Type 1 Infection
  AIDS Research and Human Retroviruses, 2000
• Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?
  The Lancet, 2000
• Genetic Characterization of Incident HIV Type 1 Subtype E and B Strains from a Prospective Cohort of Injecting Drug Users in Bangkok, Thailand
  AIDS Research and Human Retroviruses, 2000
• AIDSVAX^®(MN) in Bangkok Injecting Drug Users: A Report on Safety and Immunogenicity, Including Macrophage-Tropic Virus Neutralization
  AIDS Research and Human Retroviruses, 2000
• A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais
  Vaccine, 2000
• Development of Bivalent (B/E) Vaccines Able to Neutralize CCR5-Dependent Viruses from the United States and Thailand
  Virology, 1999
• Planning for HIV vaccine trials
  AIDS, 1991